Bloomberg
Media Bias by Omission: Bloomberg Doesn't Investigate Democratic Presidential Candidates
As of Nov. 2019, Bloomberg admits that it engages in bias by omission with a Lean Left bent. Mike Bloomberg, New York City mayor and founder of the financial software company that owns Bloomberg, officially entered the 2020 Democratic presidential race in Nov. 2019. According to a memo sent to editorial and research staff obtained by CNBC and verified by a Bloomberg spokesperson, Bloomberg News announced it would refrain from investigating Mayor Bloomberg and his Democratic rivals.
“We will continue our tradition of not investigating Mike (and his family and foundation ) and we will extend the same policy to his rivals in the Democratic primaries. We cannot treat Mike’s democratic competitors differently from him,” Editor-in-Chief John Micklethwait said in the memo.
In Dec. 2019, President Donald Trump's campaign announced it would stop credentialing Bloomberg News reporters for rallies and other events until the outlet resumed investigating Democratic candidates.
Mike Bloomberg is founder and 89% shareholder in Bloomberg LP, the financial software company that owns Bloomberg News.
Headline Roundup
Type of Content
Approved Story
1
Format
Region
News Item Format
Standard
Image Caption
Eric Baradat/AFP/Getty Images
Autocurated
0
The Biden administration will allow Florida to import cheaper prescription drugs from Canada, giving the green light to a plan put in motion by the state several years ago.
The Food and Drug Administration made the decision on Florida’s plan Friday, saying that the state’s health department must likewise provide quarterly reports to the agency, including information on cost savings and potential safety and quality issues.
FDA Commissioner Robert Califf said in a statement that the agency was “committed to working with states and Indian tribes” trying to develop importation proposals.
“These proposals must demonstrate the programs would result in significant cost savings to consumers without adding risk of exposure to unsafe or ineffective drugs,” Califf said.